N-(4-hydroxyphenyl)retinamide (4-HPR) decreases neoplastic properties of human prostate cells: An agent for prevention

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 496, Issue 1-2, 2001, Pages 163-170

  Sharp, Rebekah M ^a   Bello DeOcampo, Diana ^a   Quader, Salmaan T A ^a   Webber, Mukta M ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

4 HPR; Invasion; Prevention; Prostate cancer; Suppressor proteins; Vimentin

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOKERATIN 18; FENRETINIDE; INTERMEDIATE FILAMENT PROTEIN; PROTEIN P53; PROTEIN PRB; RETINOID; TUMOR PROTEIN; UNCLASSIFIED DRUG; VIMENTIN;

ANTINEOPLASTIC ACTIVITY; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CARCINOGENESIS; CELL ACTIVITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENT; MALE; MALIGNANT TRANSFORMATION; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR PROMOTION;

ANTICARCINOGENIC AGENTS; CELL COUNT; CELL DIVISION; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; DOSE-RESPONSE RELATIONSHIP, DRUG; FENRETINIDE; HUMANS; IMMUNOENZYME TECHNIQUES; KERATINS; MALE; NEOPLASM INVASIVENESS; PHENOTYPE; PROSTATE; PROSTATIC NEOPLASMS; RETINOBLASTOMA PROTEIN; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; VIMENTIN;

EID: 0035922184     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(01)00231-5     Document Type: Conference Paper

References (33)

1. Cancer statistics, 2000
2. Carcinoma of the prostate: Geographic distribution and risk factors
3. Prostatic intraepithelial neoplasia is a risk factor for cancer
4. The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients
5. Recent advances in chemoprevention of cancer
6. Prevention of primary prostate cancer in Lobund-Wistar rats by N-(4-hydroxyphenyl)retinamide
7. Modulation of the malignant phenotype of human prostate cancer cells by N-(-4-hydroxyphenyl)retinamide (4-HPR)
8. 4-Hydroxyphenyl-retinamide is a highly selective activator of retinoid receptors
9. Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18
10. Acinar differentiation by non-malignant immortalized human prostatic epithelial cells and its loss by malignant cells
11. Immortalized and tumorigenic adult human prostatic epithelial cell lines: Characteristics and applications. Part 2. Tumorigenic cell lines
12. Tumor suppressor genes in prostatic oncogenesis
13. p53 mutations in prostate cancer bone metastases suggest that selected p53 mutant in the primary site define foci with metastatic potential
14. Prognostic significance of p53 nuclear accumulation in localized prostate cancer treated with radical prostatectomy
15. p53: The ultimate tumor suppressor gene
16. Molecular biologic aspects of human prostatic carcinoma
17. Allelic loss of the retinoblastoma gene in primary human prostatic adenocarcinomas
18. Prostate specific antigen and androgen receptor induction and characterization of an immortalized adult human prostatic epithelial cell line
19. Immortalization of human uroepithelial cells by human papillomavirus 16 E6 or E7
20. Immortalized and tumorigenic adult human prostatic epithelial cell lines: Characteristics and applications. Part 3. Oncogenes, suppressor genes and applications
21. Differential expression of specific cytokeratin polypeptides in the basal and luminal epithelia of the human prostate
22. Keratin expression: A measure of phenotypic modulation of human prostatic epithelial cells by growth inhibitory factors
23. Differentiation state and invasiveness of human breast cancer cell lines
24. Intermediate filament expression of ductal carcinoma cells in fine needle aspirates of the breast
25. Experimental co-expression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic interconversion and increased invasive behavior
26. Alterations of the p53 gene are associated with the progression of a human prostate carcinoma
27. p53 protein accumulation and gene mutation in the progression of human prostate carcinoma
28. The effect of all-trans and 9-cis-retinoic acid on the steady state level of HPV16 E6/E7 mRNA and cell cycle in cervical carcinoma cells
29. Chemoprevention of prostate cancer: Concepts and strategies
30. Beta-carotene modulates human prostate cancer cell growth and may undergo intracellular metabolism to retinol
31. Retinoids in cancer chemoprevention
32. Synthetic retinoid CD437 induces S-phase arrest and apoptosis in human prostate cancer cells LNCaP and PC-3
33. The development of biological end points in patients treated with differentiation agents: An experience of retinoids in prostate cancer